Comparison of different automated lesion delineation methods for metabolic tumor volume of 18F-FDG PET/CT in patients with stage I lung adenocarcinoma
Authors:
Open Access
- 1 December 2017
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 96 (51) , e9365
Abstract
The aim of the study was to investigate the suitable segmentation method in small, low uptake and heterogeneous nodules of stage I lung adenocarcinoma.133 stage I lung adenocarcinoma patients with F-FDG PET/CT scans were enrolled in this retrospective study. All lesions were divided into different groups according to nodule density, nodule size, and the maximum standard uptake value (SUVmax) level. Four different PET segmentation methods were performed, including percentage threshold of SUVmax (T42% and T42% × RC), gradient-based threshold (adaptive iterative algorithm, AT-AIA), and background-related threshold (adaptive thresholding at 40% SUVmax, AT40%) approaches. The MTVs were evaluated and compared with CT volume (CTV). Percentage volume error (%VE) compared to CTV was calculated and the correlations between MTVs and CTV were analyzed.AT-AIA had the highest accuracy in large, high uptake, and solid nodules (72.5%, 72.4%, and 65.6%, respectively). AT40% had the highest accuracy in small, low uptake and nonsolid nodules (56.6%, 56.1%, and 62.6%, respectively). In part-solid nodules, the accuracy of AT-AIA (60.0%) and AT40% (56.7%) were higher than that of T42% and T42% × RC. The MTV of AT-AIA was in excellent correlation with the CTV in solid nodules (R = 0.831, P < .001) and in high uptake nodules (R = 0.830, P < .001). The MTV of AT40% was in good correlation with the CTV in nonsolid nodules (R = 0.686, P = .003) and in part-solid nodules (R = 0.731, P < .001).AT40% showed best performance in small, low uptake, nonsolid and part-solid lesions. AT-AIA was suitable for large, high uptake, and solid lesions.Keywords
This publication has 45 references indexed in Scilit:
- Differentiation of lung neoplasms with lepidic growth and good prognosis from those with poor prognosis using computer-aided 3D volumetric CT analysis and FDG-PETActa Radiologica, 2014
- Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancerNuclear Medicine Communications, 2013
- A Partial Volume Effect Correction Tailored for18F-FDG-PET Oncological StudiesBioMed Research International, 2013
- Prognostic Significance of the Number of Removed Lymph Nodes at Lobectomy in Patients with Positron Emission Tomography-Computed Tomography-Negative N2 Non-Small Cell Lung CancerOncology Research and Treatment, 2013
- Adaptive 18Fluoro-2-deoxyglucose Positron Emission Tomography/Computed Tomography-based Target Volume Delineation in Radiotherapy Planning of Head and Neck CancerClinical Oncology, 2011
- Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour sizeLung Cancer, 2011
- Geometrical Analysis of Radiotherapy Target Volume Delineation: a Systematic Review of Reported Comparison MethodsClinical Oncology, 2010
- Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.Journal of Hematology & Oncology, 2008
- Fleischner Society: Glossary of Terms for Thoracic ImagingRadiology, 2008
- The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005